Filter
208
Filtered Results: 208
Text search:
monoclonal
antibodies
Featured
Recommendations
33
New Publications
36
Language
Document type
No document type
82
Guidelines
57
Studies & Reports
28
Manuals
15
Fact sheets
11
Strategic & Response Plan
7
Resource Platforms
3
Training Material
2
Infographics
2
Situation Updates
1
Countries / Regions
India
15
Global
13
South Africa
7
Latin America and the Carribbean
5
Germany
5
Syria
3
Philippines
3
Venezuela
3
Congo, Democratic Republic of
3
Nigeria
2
Niger
2
Afghanistan
2
Africa
2
West and Central Africa
2
Middle East and North Africa
2
France
2
Spain
2
Russia
2
Mali
2
Indonesia
2
Pakistan
2
North Macedonia
1
Colombia
1
Mexico
1
Ukraine
1
El Salvador
1
Turkey
1
Benin
1
Sierra Leone
1
Rwanda
1
Kazakhstan
1
Chile
1
Cameroon
1
Senegal
1
Congo-Brazzaville
1
Burkina Faso
1
Peru
1
Morocco
1
Qatar
1
Mauritania
1
USA
1
Haiti
1
Dominican Republic
1
Tanzania
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
Western and Central Europe
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
East and Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Lebanon
1
Vietnam
1
Uganda
1
Nicaragua
1
Brazil
1
Namibia
1
Egypt
1
Sudan
1
Yemen
1
Ethiopia
1
Honduras
1
Chad
1
Libya
1
Iraq
1
Somalia
1
Liberia
1
Ecuador
1
Madagascar
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Guidelines
25
COVID-19
17
Vaccine-preventable Diseases
8
Non-communicable Diseases
7
Drugs & Medical Equipment
6
Disease Prevention & Control
6
Virology
5
Rabies
4
Pediatrics
3
Policies & Guidelines HIV & TB
3
NTDs & Others
3
Paediatrics
2
General Guidelines
2
Cancer Treatment & Resources
2
NCD
2
Hemorrhagic Fever
2
Diarrhoeal Disease/Cholera
2
Women & Child Health
2
Studies & Reports
2
Respiratory Infections
2
Immunization
2
Parasitology
2
Malaria
2
TB
2
Communicable Diseases
1
Clinical Training
1
Hepatitis
1
Public Health
1
Disaster Preparedness
1
Bacteriology
1
Cancer
1
Vector Control
1
Palliative Care
1
Infection Control & Prevention (IPC)
1
Yersinia pestis (Plague)
1
Countries
1
Yellow Fever
1
Policies
1
Information, Education and Communication (IEC)
1
Capacity Building
1
Humanitarian Crisis
1
Statistics
1
COPD/Asthma
1
Gynaecology & Obstetrics
1
Leishmaniasis
1
Laboratory Technologies
1
HIV & STI
1
Age & Elderly
1
Toolboxes
Clinical Guidelines
17
SARS-CoV-2 Variants
9
Inactivated COVID-19 Vaccines
7
Laboratory
6
Surveillance & Contact tracing
6
Genomic sequencing
6
Testing Guidelines
6
Surveillance
5
Public Health
5
Treatment Guidelines
5
Essential Medicines & Devices Lists
5
Laboratory Guidance
4
Immunization Guidelines
4
Vaxzevria (Astra Zeneca)
4
Outbreak Prevention & Control
3
Clinical Aspects, Treatment & Prevention
3
Influenza Prevention & Control
3
Research
3
Prevention & Preparedness
3
Clinical Aspects
3
Diagnostics & Laboratory Guidance
3
Country specific documents
3
Scientific & Research Studies
3
Covaxin
3
Clinical Aspects & Diagnostics
3
Disease Prevention & Control
3
Preparedness & Prevention
3
Ebola Prevention & Control
2
Influenza
2
Vaccination
2
Essential List
2
Training, others
2
Appeals and Response Plans
2
Global Impact: Socio-economic, health services, TB & HIV
2
Essential Medicines & Medical Devices
2
Fair Allocation & Ethical Aspects
2
COVAX Initiative
2
Moderna
2
Biontech/Pfizer Comirnaty
2
Infectious Diseases
2
MPOX - Monkeypox
2
Health Financing Toolbox
2
Clinical Aspects & Diagnosis
2
Statistics & Facts
2
Alzheimer's Disease & Dementia
2
Antiretroviral Treatment ART
2
Meningitis & Encephalitis
2
Drugs
1
Assessment & Studies
1
ART Drug Resistance
1
Treatment & Prevention
1
Vaccines & Immunization
1
Yellow Fever
1
Clinical Guidelines
1
Country specific
1
Key Resources
1
Children & Adolescents
1
Plague
1
Drug resistance
1
Cholera Prevention & Control
1
Latin America
1
Ebola & Marburg
1
Ebola
1
Public Health
1
International
1
Climate & Health
1
Context & Facts
1
Situation Reports & Updates
1
Research & Development
1
Studies
1
Public Health
1
Risk Communication & Community Engagement
1
For General Public & Community
1
For Health Worker
1
Oxygen Therapy
1
Situation Reports COVID-19
1
Access & Strategy
1
Vaccine Candidates & Research
1
Non-pharmaceutical interventions (NPIs)
1
Presentation
1
Long COVID/ Post-COVID Syndrome
1
Vector-based Vacines General
1
Johnson & Johnson
1
Research & Pipeline
1
Essential Medicines
1
Quality Assurance
1
General documents One Health
1
Guidelines & Manuals
1
Zoonoses
1
Health Impact & Climate Change
1
Strategies & Roadmaps
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Taeniasis/Cysticercosis
1
Access to treatment and laboratory
1
General Information & Methodology
1
Prevention & Strategies
1
Studies & Reports
1
Clinical Aspects & Diagnosis
1
Prevention & Strategies
1
Studies & Reports
1
Clinical Guidelines
1
Neurological Disorders
1
Zika
1
Diarrhoea
1
Clinical Guidelines
1
Chikungunya Prevention & Control
1
Clinical Guidelines
1
Laboratory
1
Context & Facts
1
Marburg Virus Situation Reports
1
Chikungunya
1
Laboratory & Diagnostics
1
Action Plans, Policies & Response
1
AMR
1
Public Health
1
Plague Prevention & Control
1
Weekly epidemiological record/ Relevé épidémiologique hebdomadaire 4 AUGUST 2017, 92th YEAR / 4 AOÛT 2017, 417-436
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
BMC Medicine (2015) 13:42 DOI 10.1186/s12916-014-0263-6
Prepared as an outcome of ICMR Expert Group on Immunophenotyping of Hematolymphoid Neoplasms | Coordinated by Division of Non Communicable Diseases | This document addresses on various issue related to good quality practices in laboratory work up of flow cytometric immunophenotyping and will be of u...
Prepared as an outcome of ICMR Subcommittee on Multiple Myeloma | This consensus document on management of multiple myeloma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also i...
Responding to a poliovirus event and outbreak, Part 1: General (SOPs) describes the general principles and steps to facilitate timely and effective responses to poliovirus events and outbreaks, and incorporate lessons learned from recent previous outbreak response efforts. This document summarizes r...
The main objectives of the SOPs are to: (i) establish standards and timelines for response activities; and (ii) guide national governments and GPEI partners in key support functions.
This new version of the SOPs presents overall response requirements for dealing with type 1, 2 and 3 poliovirus fo...
Presentation is current through November 21, 2014 and will be updated every Friday by 5pm. For the most up-to-date information, please visit www.cdc.gov/ebola.
*Presentation contains materials from CDC, MSF, and WHO
This document builds on the Background document prepared for the September 4-5, 2014 Consultation. It includes proposed elements to consider during the development of a framework to assist decision-making at global and national level.
The aim of the document is to assist Member States and releva...
Infectious Diseases of Poverty 2014, 3:42
http://www.idpjournal.com/content/3/1/42
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
The document is intended to facilitate the detection, evaluation and management of incident EVD cases in Germany. It primarily addresses public health service staff and health care workers in hospitals, outpatient clinics and emergency services in Germany. It is a work in progress, intended to evolv...
This WHO information note provides an updated list of recommended criteria for selecting RDTs for malaria, and highlights the performance of RDTs evaluated by the WHO malaria RDT product testing programme. It also provides an overview of additional considerations in the procurement of rapid tests.
Namibia guideline for submission of applications for registration of pharmaceuticals for human use in common technical document format.
Epidemics of infectious diseases are occurring more often, and spreading faster and further than ever, in many different regions of the world. The background factors of this threat are biological, environmental and lifestyle changes, among others. A potentially fatal combination of newly-discovered ...
